Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (341-350 of 344) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 344 results.
The Journal of Experimental Medicine|June 2, 2017
Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic diseaseStefan Uderhardt, Jochen A Ackermann, Tobias Fillep, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2026
Global survey of women's awareness of pregnancy- and postpartum-associated venous thromboembolism (World Thrombosis Day 2025)Marcello Di Nisio, Isabelle Mahé, Parham Sadeghipour, et al.
The Lancet. Haematology|September 2, 2022
Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendationAdam M Gwozdz, Cindy M M de Jong, Luz Sousa Fialho, et al.
Pageof 35

Showing results (341-350 of 344) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 344 results.
The Journal of Experimental Medicine|June 2, 2017
Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic diseaseStefan Uderhardt, Jochen A Ackermann, Tobias Fillep, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2026
Global survey of women's awareness of pregnancy- and postpartum-associated venous thromboembolism (World Thrombosis Day 2025)Marcello Di Nisio, Isabelle Mahé, Parham Sadeghipour, et al.
The Lancet. Haematology|September 2, 2022
Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendationAdam M Gwozdz, Cindy M M de Jong, Luz Sousa Fialho, et al.
Pageof 35